Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
Journal article published in 2019 by
Janice M. Mehnert,
Andrea Varga,
Marcia S. Brose,
Rahul R. Aggarwal,
Chia-Chi Lin,
Amy Prawira,
Filippo de Braud,
Kenji Tamura,
Toshihiko Doi,
Sarina A. Piha-Paul 
,
Jill Gilbert,
Sanatan Saraf,
Pradeep Thanigaimani,
Jonathan D. Cheng,
Bhumsuk Keam
,
Jill Gilbert,
Sanatan Saraf,
Pradeep Thanigaimani,
Jonathan D. Cheng,
Bhumsuk Keam
This paper is made freely available by the publisher.
Full text: Download
Data provided by 